Changing the Game in Drug Development Brochure 医薬品開発の大変革 At Certara, we are innovators, dedicated to helping our clients develop new therapies and target…Danielle Pillsbury2018年3月19日
Using a Pharmacology to Payer Framework to Support Product Development Blog Using a Pharmacology to Payer Framework to Support Product Development Modeling and simulation (M&S) of complex systems has primarily advanced vertically in differing scientific domains…Certara2018年3月16日
An Analysis on Distribution and Inter-relationships of Biomarkers Under Rivaroxaban in Japanese Patients with Non-valvular Atrial Fibrillation (CVI ARO 1) Publication An Analysis on Distribution and Inter-relationships of Biomarkers Under Rivaroxaban in Japanese Patients with Non-valvular Atrial Fibrillation (CVI ARO 1) Danielle Pillsbury2018年3月15日
The Many Challenges of Narrative Writing Blog The Many Challenges of Narrative Writing Narratives are an essential part of any programs’ story, but often become cumbersome due to…Certara2018年3月13日
Using Virtual Twin Technology to Predict Drug Exposure in Individual Patients On-Demand Webinar Using Virtual Twin Technology to Predict Drug Exposure in Individual Patients In this webinar, Dr. Tom Polasek, a clinical pharmacologist at Certara Strategic Consulting, explained how…Danielle Pillsbury2018年3月8日
Skin in the Game: Mechanistic Modeling of Dermal Drug Absorption Blog Skin in the Game: Mechanistic Modeling of Dermal Drug Absorption The ability to estimate systemic exposure from dermal absorption is essential in developing new dermatological…Certara2018年3月2日
Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics Publication Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics Danielle Pillsbury2018年3月1日